An electrochemiluminescent label converts electrical stimulation into a measurable optical signal. When an electrode receives an electrical potential, the label emits light, and the resulting intensity reflects the amount of analyte present. This mechanism supports sensitive quantification because the assay links a controlled electrical stimulus directly to a concentration-dependent light measurement.
Patterned multi-array plates organize separate assay regions within one plate, allowing different capture and detection reagent combinations to measure different targets. Multiple biomarkers can therefore be assessed simultaneously in a small sample volume. This arrangement increases the amount of biological information obtained from each sample while preserving target-specific measurements within the multiplex assay.
Sandwich and competitive formats offer different ways to organize binding measurements. In a sandwich assay, the target is associated with capture and detection reagents, whereas a competitive assay uses an alternative immunoassay arrangement. This flexibility allows Meso Scale Discovery studies to accommodate different biological analytes and select a format suited to the measurement goal.
Capture and detection reagents provide the molecular recognition step that links a biological analyte to the assay readout. Their interaction with the target determines which molecule is measured, while the electrochemiluminescent label converts that binding event into detectable light. This connection between selective binding and signal enables quantitative analysis of proteins, antibodies, and other analytes.
A typical workflow brings the biological sample into contact with capture and detection reagents on a patterned multi-array plate. After target binding occurs, the assay applies an electrical potential to stimulate the electrochemiluminescent labels, then uses signal intensity to quantify the analyte. The sequence combines target recognition, multiplex organization, and quantitative readout.
In biology, Meso Scale Discovery assays can support biomarker validation, disease research, pharmacology, and monitoring of therapeutic responses. The resulting measurements help investigators examine several biomarkers at once and relate their concentrations to a biological or treatment-related question. This makes the platform relevant when researchers need quantitative protein or antibody data from limited sample material.